Surgery Partners, Inc. Announces $50.0 Million Share Repurchase Program
15 Dezember 2017 - 02:00PM
Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or
the "Company"), a leading provider of surgical services, today
announced that its Board of Directors has authorized a share
repurchase program under which the Company may repurchase up to
$50.0 million of its common stock.
Clifford Adlerz, Interim Chief Executive Officer of Surgery
Partners, stated “The authorization of this share repurchase
program underscores our commitment to creating value for our
shareholders and our belief in the strength of our business and its
underlying industry trends. We have a strong, diversified platform
and see the opportunity to drive growth and optimize performance,
creating value in our shares at the current valuation. We intend to
maintain ample capital to support both internal and
acquisition-based growth initiatives in line with our long-term
strategy.”
The timing and size of repurchases will be determined based on
market conditions and other factors. The authorization does not
obligate the Company to repurchase any shares and the Company may
repurchase shares of common stock at any time without prior notice.
The Company’s share repurchases will be made in accordance with
applicable securities laws in open market or privately negotiated
transactions. The authorization does not have a specified
expiration date, and the share repurchase program may be suspended,
recommenced or discontinued at any time or from time to time
without prior notice.
Forward-Looking Statements
This press release contains forward-looking statements,
including those attributed to our Interim Chief Executive Officer.
These statements involve risks and uncertainties and assumptions
relating to our operations, financial condition, business,
prospects, growth strategy and liquidity, which may cause our
actual results to differ materially from those projected by such
forward-looking statements. You can identify forward-looking
statements because they do not relate strictly to historical or
current facts. These statements may include words such as “aim,”
“anticipate,” “believe,” “estimate,” “expect,” “forecast,”
“outlook,” “potential,” “project,” “projection,” “plan,” “intend,”
“seek,” “may,” “could,” “would,” “will,” “should,” “can,” “can
have,” “likely,” and other words and terms of similar meaning in
connection with any discussion of the timing or nature of future
operating or financial performance, the perceived value in our
shares at current valuations or other events.
All forward-looking statements are subject to risks and
uncertainties, including but not limited to those risks and
uncertainties described in “Risk Factors” in our Quarterly Report
on Form 10-Q for the quarter ended June 30, 2017 that may cause
actual results to differ materially from those that we
expected.
The forward-looking statements made in this press release are
made only as of the date of the hereof. Except as required by law,
we undertake no obligation to update any forward-looking statement,
whether as a result of new information or otherwise. More
information about potential factors that could affect our business
and financial results is included in our filings with
the Securities and Exchange Commission.
About Surgery Partners
Headquartered in Brentwood, Tennessee, Surgery Partners is a
leading healthcare services company with a differentiated
outpatient delivery model focused on providing high quality, cost
effective solutions for surgical and related ancillary care in
support of both patients and physicians. Founded in 2004, Surgery
Partners is one of the largest and fastest growing surgical
services businesses in the country, with more than 150 locations in
29 states, including ambulatory surgery centers, surgical
hospitals, a diagnostic laboratory, multi-specialty physician
practices and urgent care facilities.
Contact
FTI Consulting(615) 234-8940IR@surgerypartners.com
Surgery Partners (NASDAQ:SGRY)
Historical Stock Chart
Von Feb 2024 bis Mär 2024
Surgery Partners (NASDAQ:SGRY)
Historical Stock Chart
Von Mär 2023 bis Mär 2024